Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 18: | Line 18: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
|- | |- | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Cutaneous squamous cell carcinoma''' | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Cutaneous squamous cell carcinoma]]''' | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''SCC in situ (Bowen's disease''') | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Squamous cell carcinoma in situ of skin|'''SCC in situ (Bowen's disease''')]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Scaly patch or plaque | * Scaly patch or plaque | ||
Line 34: | Line 34: | ||
* In black individuals: legs, anus, areas of chronic inflammation | * In black individuals: legs, anus, areas of chronic inflammation | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Presence of dotted +/- glomerular vessels | |||
* White to yellowish surface scales | |||
* Red-yellowish background color | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Keratinocytic dysplasia involving the full thickness of the epidermis | * Keratinocytic dysplasia involving the full thickness of the epidermis | ||
Line 60: | Line 63: | ||
* In black individuals: legs, anus, areas of chronic inflammation | * In black individuals: legs, anus, areas of chronic inflammation | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* White circles | |||
* White structureless areas | |||
* Masses of keratin | |||
* Hairpin and linear-irregular vessels | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Keratinocytic dysplasia involving the full thickness of the epidermis | * Keratinocytic dysplasia involving the full thickness of the epidermis | ||
Line 69: | Line 76: | ||
* May be painful or pruritic | * May be painful or pruritic | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Keratoacanthoma''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Keratoacanthoma]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Small macule initially | * Small macule initially | ||
Line 97: | Line 104: | ||
* Rapid growth (within weeks) | * Rapid growth (within weeks) | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Merkel cell carcinoma''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Merkel cell carcinoma]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Intracutaneous nodule | * Intracutaneous nodule | ||
Line 129: | Line 136: | ||
* Usually in older patients with light skin tones | * Usually in older patients with light skin tones | ||
|- | |- | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Basal cell carcinoma''' | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Basal cell carcinoma]]''' | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular basal cell carcinoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Nodular basal cell carcinoma]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Papule | * Papule | ||
Line 141: | Line 148: | ||
* Face | * Face | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Focused, bright red, and branching arborizing vessels | |||
* Loosely arranged blue-gray dots | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 156: | Line 165: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Shiny white to red, translucent or opaque structureless areas | |||
* Multiple small erosions | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* large, hyperchromatic, oval nuclei and little cytoplasm | * large, hyperchromatic, oval nuclei and little cytoplasm | ||
Line 186: | Line 197: | ||
* Worsened by heat, sweating, or irritation from clothing | * Worsened by heat, sweating, or irritation from clothing | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Common nevus''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Nevus|Common nevus]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Dome-shaped nodules | * Dome-shaped nodules | ||
Line 204: | Line 215: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Blue nevus''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Blue nevus]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Macules | * Macules | ||
Line 260: | Line 271: | ||
* Most commonly develops in children, adolescents, and young adults. | * Most commonly develops in children, adolescents, and young adults. | ||
|- | |- | ||
| rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Melanoma''' | | rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Melanoma]]''' | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Melanoma in situ''' (Lentigo Maligna) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Melanoma in situ''' (Lentigo Maligna) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 283: | Line 294: | ||
* Development of darker pigmentation, sharper borders, or nodular areas are signs of progression to lentigo maligna melanoma | * Development of darker pigmentation, sharper borders, or nodular areas are signs of progression to lentigo maligna melanoma | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo maligna melanoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Lentigo maligna melanoma]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Macule | * Macule | ||
Line 306: | Line 317: | ||
* Usually in older individuals | * Usually in older individuals | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial spreading melanoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Superficial spreading melanoma]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Macule | * Macule | ||
Line 328: | Line 339: | ||
* Lateral (radial) growth before vertical (invasive) growth | * Lateral (radial) growth before vertical (invasive) growth | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular melanoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Nodular melanoma]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Polypoid nodule | * Polypoid nodule | ||
Line 345: | Line 356: | ||
* Two-thirds arise in normal skin, the rest in existing moles | * Two-thirds arise in normal skin, the rest in existing moles | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Acral lentiginous melanoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Acral lentiginous melanoma]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Macules | |||
* Patches | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Dark brown to black | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Raised areas | |||
* Ulceration | |||
* Bleeding | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | * Variable | ||
Line 359: | Line 376: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Most common among dark skinned individuals | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Amelanotic melanoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Amelanotic melanoma]]''' | ||
| style="background: #F5F5F5; padding: 5px;" |Color usually pink, purple or normal skin color | | style="background: #F5F5F5; padding: 5px;" |Color usually pink, purple or normal skin color | ||
| style="background: #F5F5F5; padding: 5px;" |Usually have an asymmetrical shape with an irregular border | | style="background: #F5F5F5; padding: 5px;" |Usually have an asymmetrical shape with an irregular border | ||
Line 372: | Line 390: | ||
* | * | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Solar lentigo''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Solar lentigo]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Multiple spots | * Multiple spots | ||
Line 391: | Line 409: | ||
* Associated with UV exposure and skin aging | * Associated with UV exposure and skin aging | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sebaceous hyperplasia''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Sebaceous hyperplasia]]''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Papules | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Skin-colored to brownish | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Umbilicated | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * 2 - 6 mm | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Forehead | |||
* Nose | |||
* Cheeks | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Structureless yellow to whitish center surrounded by short linear "crown vessels" | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Usually in middle-aged or older patients | |||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lichen planus-like keratosis''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lichen planus-like keratosis''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Papule | |||
* Plaque | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Gray to brown | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 410: | Line 439: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Shows a coarse or fine, gray to blue, granular pigmentation | |||
* Diffuse brownish gray granules | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 424: | Line 455: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratosis''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Actinic keratosis]]''' | ||
| style="background: #F5F5F5; padding: 5px;" |less pigmentation, and tend to be somewhat smaller in size. | | style="background: #F5F5F5; padding: 5px;" |less pigmentation, and tend to be somewhat smaller in size. | ||
| style="background: #F5F5F5; padding: 5px;" |Erythema | | style="background: #F5F5F5; padding: 5px;" |Erythema |
Revision as of 03:56, 19 February 2019
Diseases | Physical exam | Para-clinical findings | Additional findings | ||||||
---|---|---|---|---|---|---|---|---|---|
Skin Examination | |||||||||
Diagnosis | |||||||||
Type | Color | Texture | Size | Distribution | Dermoscopic Findings | Histopathology | |||
Cutaneous squamous cell carcinoma | SCC in situ (Bowen's disease) |
|
|
|
|
|
|
|
|
Invasive squamous cell carcinoma |
|
|
|
|
|
|
|
| |
Keratoacanthoma |
|
|
|
|
|
|
|
| |
Merkel cell carcinoma |
|
|
|
|
|
|
|
| |
Basal cell carcinoma | Nodular basal cell carcinoma |
|
|
|
|
|
| ||
Superficial basal cell carcinoma |
|
|
|
|
|
|
|||
Prurigo nodules |
|
|
|
|
|
|
| ||
Common nevus |
|
|
|
|
|
||||
Blue nevus |
|
|
|
|
|
||||
Spitz nevus | Nonpigmented Spitz nevus |
|
|
|
|
|
| ||
Reed-like Spitz |
|
|
|
|
| ||||
Melanoma | Melanoma in situ (Lentigo Maligna) |
|
|
|
|
|
|
|
|
Lentigo maligna melanoma |
|
|
|
|
|
|
|
| |
Superficial spreading melanoma |
|
|
|
|
|
|
| ||
Nodular melanoma |
|
|
|
|
| ||||
Acral lentiginous melanoma |
|
|
|
|
|
| |||
Amelanotic melanoma | Color usually pink, purple or normal skin color | Usually have an asymmetrical shape with an irregular border | Red, nonspecific lesion with slightly elevated borders |
| |||||
Solar lentigo |
|
|
|
|
|
| |||
Sebaceous hyperplasia |
|
|
|
|
|
|
| ||
Lichen planus-like keratosis |
|
|
|
|
|||||
Seborrheic keratosis |
|
||||||||
Actinic keratosis | less pigmentation, and tend to be somewhat smaller in size. | Erythema | Hyperkeratosis | painful |
SCC in situ: Frequently, there is associated thickening of the epidermis (acanthosis), as well as hyperkeratosis and parakeratosis of the stratum corneum. In contrast to SCC in situ, actinic keratoses demonstrate only partial-thickness epidermal dysplasia.